Meyer James's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Sep 1, 2026
- Accession no.
- 0000097745-26-000166
- Filed
- Sep 1, 2026, 4:11 PM ET
- Trade date
- Aug 28, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Meyer JamesCIK 0002115686 | Officer (Sr. Vice President & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −37.23 | $622.18 | −$23,163.76 | 5,792.808 | Direct | |
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −44.483 | $622.18 | −$27,676.43 | 5,748.325 | Direct | |
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −19.824 | $622.18 | −$12,334.1 | 5,728.501 | Direct | |
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −55.12 | $622.18 | −$34,294.56 | 5,673.381 | Direct | |
| Aug 28, 2026 | Common Stock | FTax withholdingDisposed | −113.623 | $622.18 | −$70,693.96 | 5,559.758 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.